2m 2m 2m 2m 2m 2m 2m
TAYSHA GENE THER (TSHA)
NASDAQ
$6.94+$0.41 (+6.31%)
Price as of Jun 23, 2026 6:43 PM EDT- $1.9BMarket Cap
- 162.25%1-Year Change
- BiotechnologyIndustry
TAYSHA GENE THER (TSHA)
$6.94+$0.41 (+6.31%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.8M +17.28% | 8.3M -46.07% | 15.5M +517.55% | 2.5M N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 9.8M +17.28% | 8.3M -46.07% | 15.5M +517.55% | 2.5M N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -86.4M +30.91% | -66.0M +16.24% | -56.8M -37.72% | -91.2M -30.90% | |
Depreciation and Amortization Expense | 1.1M -8.03% | 1.2M -9.19% | 1.4M +16.98% | 1.2M +138.21% | |
Total Operating Expenses | 120.3M +20.52% | 99.8M +13.54% | 87.9M -46.72% | 164.9M -4.80% | |
Operating Profit | -110.5M +20.82% | -91.5M +26.26% | -72.4M -55.41% | -162.4M -6.24% | |
Interest Income | 9.2M +32.91% | 6.9M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -5.0M +31.60% | -3.8M +165.97% | |
Interest Income and Expense and Net | 9.2M +32.91% | 6.9M +238.86% | -5.0M +31.60% | -3.8M +165.97% | |
Total Nonoperating Income and Expense | 1.5M -30.45% | 2.2M +105.52% | -39.1M +996.92% | -3.6M +184.00% | |
Income before Taxes | -110.5M +20.82% | -91.5M +26.26% | -72.4M -55.41% | -162.4M -6.24% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 4.8M 0.00% | 4.8M +700.00% | 600,000 N/A | N/A N/A | |
Net Income | -109.0M +22.06% | -89.3M -19.96% | -111.6M -32.80% | -166.0M -4.88% | |
Net Income from Continuing Operations Applicable to Common | -109.0M +22.06% | -89.3M -19.96% | -111.6M -32.80% | -166.0M -4.88% | |
Basic EPS and Net Income | -0.34 -5.56% | -0.36 -62.50% | -0.96 -74.60% | -3.78 -18.53% | |
Diluted EPS and Net Income | -0.34 -5.56% | -0.36 -62.50% | -0.96 -74.60% | -3.78 -18.53% | |
Basic Weighted Average Shares | 319.7M +27.82% | 250.1M +115.41% | 116.1M +164.20% | 44.0M +16.74% | |
Diluted Weighted Average Shares | 319.7M +27.82% | 250.1M +115.41% | 116.1M +164.20% | 44.0M +16.74% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 319.8M +129.99% | 139.0M -3.41% | 143.9M +63.79% | 87.9M -41.06% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 319.8M +129.99% | 139.0M -3.41% | 143.9M +63.79% | 87.9M -41.06% | |
Total Current Assets | 324.6M +128.42% | 142.1M -5.16% | 149.9M +55.44% | 96.4M -39.59% | |
Accumulated Depreciation | 4.7M +30.69% | 3.6M +20.31% | 3.0M +81.43% | 1.6M +229.06% | |
Property and Plant and Equipment and Net | 6.7M -10.01% | 7.5M -30.86% | 10.8M -27.65% | 15.0M -70.43% | |
Total Long-Term Assets | 183,000 -15.67% | 217,000 -28.62% | 304,000 -76.90% | 1.3M +199.09% | |
Total Assets | 343.3M +114.09% | 160.4M -7.16% | 172.7M +36.79% | 126.3M -40.98% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 26.6M +1.24% | 26.2M -28.65% | 36.8M -41.46% | 62.8M +21.34% | |
Total Long-Term Debt | 50.1M +14.03% | 43.9M +8.48% | 40.5M +6.69% | 38.0M +2.08% | |
Total Long-Term Liabilities | 1.6M +18.56% | 1.3M -16.99% | 1.6M -61.82% | 4.1M +10.58% | |
Total Liabilities | 96.4M +8.49% | 88.8M -9.16% | 97.8M -21.97% | 125.3M +5.70% | |
Retained Earnings | -711.3M +18.10% | -602.3M +17.41% | -513.0M +27.79% | -401.4M +70.36% | |
Total Stockholders Equity | 246.9M +245.25% | 71.5M -4.55% | 74.9M +7,796.42% | 949,000 -99.01% | |
Total Shares Outstanding | 285.1M +39.09% | 204.9M +9.62% | 187.0M +195.79% | 63.2M +64.29% | |
Cash Flow | |||||
Cash from Operating Activities | -93.1M +14.61% | -81.2M +11.24% | -73.0M -17.39% | -88.4M -24.48% | |
Capital Expenditures | 738,000 +97.33% | 374,000 -90.33% | 3.9M -81.24% | 20.6M +34.73% | |
Cash from Investing Activities | -604,000 +66.39% | -363,000 -95.06% | -7.4M -70.51% | -24.9M +15.66% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 274.6M +258.08% | 76.7M -43.78% | 136.4M +161.81% | 52.1M +33.30% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,130.65% +3.02% | -1,097.55% +134.10% | -468.83% -92.78% | -6,492.69% N/A | |
Return on Assets | -43.28% -19.28% | -53.62% -28.15% | -74.62% -23.53% | -97.59% +32.20% | |
Return on Equity | -68.45% -43.87% | -121.94% -58.53% | -294.04% -14.69% | -344.67% +242.34% | |
Revenue Growth | 17.28% +137.51% | -46.07% -108.90% | 517.55% N/A | N/A N/A | |
Current Ratio | 12.23 +125.62% | 5.42 +32.91% | 4.08 +165.54% | 1.54 -50.22% | |
Cash Ratio | 12.04 +127.17% | 5.30 +35.37% | 3.92 +179.80% | 1.40 -51.43% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow